Recruitment
prostate cancer
PROSTATE CANCER
The trial was advertised through posters in the prostate cancer clinic of the CHU de Québec‐Université Laval. When the prostate cancer diagnosis was ascertained, the urologist informed the patient about the various treatment options. When RP was selected as the primary treatment, the urologist briefly informed the patient about the study and referred him to a research nurse who explained it in more detail and obtained written consent of patients agreeing to participate. Between February 2015 and June 2017, 397 patients were assessed for eligibility, and 130 of them (32.7%) agreed to participate and were randomized (see Figure Participants' flowchart.